nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—Renal tubular disorder—Cisplatin—esophageal cancer	0.0649	0.0746	CcSEcCtD
Emtricitabine—Floxuridine—TYMP—esophageal cancer	0.0598	0.814	CrCbGaD
Emtricitabine—DCK—Pyrimidine salvage reactions—TYMP—esophageal cancer	0.0233	0.414	CbGpPWpGaD
Emtricitabine—Hepatic steatosis—Capecitabine—esophageal cancer	0.023	0.0264	CcSEcCtD
Emtricitabine—Amylase increased—Cisplatin—esophageal cancer	0.0198	0.0227	CcSEcCtD
Emtricitabine—Rash macular—Capecitabine—esophageal cancer	0.0169	0.0194	CcSEcCtD
Emtricitabine—Hypophosphataemia—Cisplatin—esophageal cancer	0.0162	0.0186	CcSEcCtD
Emtricitabine—Prurigo—Capecitabine—esophageal cancer	0.015	0.0173	CcSEcCtD
Emtricitabine—Osteonecrosis—Methotrexate—esophageal cancer	0.0139	0.0159	CcSEcCtD
Emtricitabine—Opportunistic infection—Methotrexate—esophageal cancer	0.0128	0.0147	CcSEcCtD
Emtricitabine—Hypertriglyceridaemia—Capecitabine—esophageal cancer	0.0121	0.0139	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Capecitabine—esophageal cancer	0.0117	0.0134	CcSEcCtD
Emtricitabine—Infection—Carboplatin—esophageal cancer	0.0114	0.0131	CcSEcCtD
Emtricitabine—DCK—Pyrimidine metabolism—TYMP—esophageal cancer	0.0106	0.189	CbGpPWpGaD
Emtricitabine—Blood triglycerides increased—Capecitabine—esophageal cancer	0.0106	0.0122	CcSEcCtD
Emtricitabine—Haemoglobin decreased—Capecitabine—esophageal cancer	0.0101	0.0116	CcSEcCtD
Emtricitabine—Lamivudine—ABCC2—esophageal cancer	0.00996	0.136	CrCbGaD
Emtricitabine—Hepatomegaly—Capecitabine—esophageal cancer	0.00981	0.0113	CcSEcCtD
Emtricitabine—Pain—Carboplatin—esophageal cancer	0.0098	0.0113	CcSEcCtD
Emtricitabine—Body temperature increased—Carboplatin—esophageal cancer	0.00906	0.0104	CcSEcCtD
Emtricitabine—Otitis media—Capecitabine—esophageal cancer	0.00892	0.0102	CcSEcCtD
Emtricitabine—Multiple fractures—Methotrexate—esophageal cancer	0.0089	0.0102	CcSEcCtD
Emtricitabine—Fracture—Methotrexate—esophageal cancer	0.0089	0.0102	CcSEcCtD
Emtricitabine—Neuropathy—Cisplatin—esophageal cancer	0.00885	0.0102	CcSEcCtD
Emtricitabine—Skin hyperpigmentation—Methotrexate—esophageal cancer	0.00869	0.00999	CcSEcCtD
Emtricitabine—Proteinuria—Capecitabine—esophageal cancer	0.0079	0.00908	CcSEcCtD
Emtricitabine—Protein urine present—Capecitabine—esophageal cancer	0.00779	0.00896	CcSEcCtD
Emtricitabine—Polyuria—Cisplatin—esophageal cancer	0.00779	0.00895	CcSEcCtD
Emtricitabine—Skin discolouration—Capecitabine—esophageal cancer	0.00769	0.00883	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.00764	0.00877	CcSEcCtD
Emtricitabine—Renal failure acute—Cisplatin—esophageal cancer	0.00741	0.00851	CcSEcCtD
Emtricitabine—Bone pain—Capecitabine—esophageal cancer	0.00725	0.00833	CcSEcCtD
Emtricitabine—Inflammation—Capecitabine—esophageal cancer	0.00716	0.00823	CcSEcCtD
Emtricitabine—Neuropathy—Capecitabine—esophageal cancer	0.00652	0.00749	CcSEcCtD
Emtricitabine—Blood creatinine increased—Cisplatin—esophageal cancer	0.00641	0.00736	CcSEcCtD
Emtricitabine—Urine output increased—Capecitabine—esophageal cancer	0.00628	0.00721	CcSEcCtD
Emtricitabine—Hypokalaemia—Cisplatin—esophageal cancer	0.00622	0.00715	CcSEcCtD
Emtricitabine—Breast disorder—Cisplatin—esophageal cancer	0.00618	0.0071	CcSEcCtD
Emtricitabine—Nasopharyngitis—Cisplatin—esophageal cancer	0.00612	0.00703	CcSEcCtD
Emtricitabine—Proteinuria—Methotrexate—esophageal cancer	0.00588	0.00676	CcSEcCtD
Emtricitabine—Protein urine present—Methotrexate—esophageal cancer	0.0058	0.00667	CcSEcCtD
Emtricitabine—Pancreatitis—Cisplatin—esophageal cancer	0.0058	0.00666	CcSEcCtD
Emtricitabine—Polyuria—Capecitabine—esophageal cancer	0.00574	0.0066	CcSEcCtD
Emtricitabine—Skin discolouration—Methotrexate—esophageal cancer	0.00572	0.00658	CcSEcCtD
Emtricitabine—Gastroenteritis—Capecitabine—esophageal cancer	0.00569	0.00653	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.00569	0.00653	CcSEcCtD
Emtricitabine—Renal failure acute—Capecitabine—esophageal cancer	0.00546	0.00627	CcSEcCtD
Emtricitabine—Inflammation—Methotrexate—esophageal cancer	0.00533	0.00612	CcSEcCtD
Emtricitabine—Renal impairment—Capecitabine—esophageal cancer	0.0053	0.00609	CcSEcCtD
Emtricitabine—Dermatitis bullous—Capecitabine—esophageal cancer	0.00527	0.00606	CcSEcCtD
Emtricitabine—Renal failure—Cisplatin—esophageal cancer	0.00518	0.00595	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00517	0.00594	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.00498	0.00573	CcSEcCtD
Emtricitabine—Blood creatinine increased—Capecitabine—esophageal cancer	0.00472	0.00543	CcSEcCtD
Emtricitabine—Urine output increased—Methotrexate—esophageal cancer	0.00467	0.00537	CcSEcCtD
Emtricitabine—Urinary tract disorder—Cisplatin—esophageal cancer	0.00467	0.00537	CcSEcCtD
Emtricitabine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00465	0.00534	CcSEcCtD
Emtricitabine—Urethral disorder—Cisplatin—esophageal cancer	0.00464	0.00533	CcSEcCtD
Emtricitabine—Hypokalaemia—Capecitabine—esophageal cancer	0.00459	0.00527	CcSEcCtD
Emtricitabine—Breast disorder—Capecitabine—esophageal cancer	0.00456	0.00523	CcSEcCtD
Emtricitabine—Nasopharyngitis—Capecitabine—esophageal cancer	0.00451	0.00518	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00445	0.00511	CcSEcCtD
Emtricitabine—Muscular weakness—Capecitabine—esophageal cancer	0.00445	0.00511	CcSEcCtD
Emtricitabine—Polyuria—Methotrexate—esophageal cancer	0.00427	0.00491	CcSEcCtD
Emtricitabine—Immune system disorder—Cisplatin—esophageal cancer	0.00427	0.00491	CcSEcCtD
Emtricitabine—Mediastinal disorder—Cisplatin—esophageal cancer	0.00426	0.0049	CcSEcCtD
Emtricitabine—DCK—Nucleotide metabolism—TYMP—esophageal cancer	0.00414	0.0736	CbGpPWpGaD
Emtricitabine—Malnutrition—Cisplatin—esophageal cancer	0.00412	0.00473	CcSEcCtD
Emtricitabine—Neutropenia—Capecitabine—esophageal cancer	0.00407	0.00468	CcSEcCtD
Emtricitabine—Renal failure acute—Methotrexate—esophageal cancer	0.00406	0.00467	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00405	0.00465	CcSEcCtD
Emtricitabine—Weight decreased—Capecitabine—esophageal cancer	0.00394	0.00453	CcSEcCtD
Emtricitabine—Hyperglycaemia—Capecitabine—esophageal cancer	0.00393	0.00452	CcSEcCtD
Emtricitabine—Pneumonia—Capecitabine—esophageal cancer	0.00391	0.00449	CcSEcCtD
Emtricitabine—Infestation NOS—Capecitabine—esophageal cancer	0.00388	0.00446	CcSEcCtD
Emtricitabine—Infestation—Capecitabine—esophageal cancer	0.00388	0.00446	CcSEcCtD
Emtricitabine—Depression—Capecitabine—esophageal cancer	0.00387	0.00445	CcSEcCtD
Emtricitabine—Renal failure—Capecitabine—esophageal cancer	0.00382	0.00439	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00381	0.00438	CcSEcCtD
Emtricitabine—Anaemia—Cisplatin—esophageal cancer	0.00381	0.00437	CcSEcCtD
Emtricitabine—Urinary tract infection—Capecitabine—esophageal cancer	0.00378	0.00434	CcSEcCtD
Emtricitabine—Haematuria—Capecitabine—esophageal cancer	0.0037	0.00426	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.00367	0.00422	CcSEcCtD
Emtricitabine—Lamivudine—ABCB1—esophageal cancer	0.00366	0.0499	CrCbGaD
Emtricitabine—Myalgia—Cisplatin—esophageal cancer	0.00351	0.00403	CcSEcCtD
Emtricitabine—Rhinitis—Capecitabine—esophageal cancer	0.0035	0.00402	CcSEcCtD
Emtricitabine—Anxiety—Cisplatin—esophageal cancer	0.00349	0.00401	CcSEcCtD
Emtricitabine—Hepatitis—Capecitabine—esophageal cancer	0.00349	0.00401	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00348	0.004	CcSEcCtD
Emtricitabine—Pharyngitis—Capecitabine—esophageal cancer	0.00346	0.00398	CcSEcCtD
Emtricitabine—Urinary tract disorder—Capecitabine—esophageal cancer	0.00344	0.00396	CcSEcCtD
Emtricitabine—Connective tissue disorder—Capecitabine—esophageal cancer	0.00343	0.00394	CcSEcCtD
Emtricitabine—Urethral disorder—Capecitabine—esophageal cancer	0.00342	0.00393	CcSEcCtD
Emtricitabine—Breast disorder—Methotrexate—esophageal cancer	0.00339	0.0039	CcSEcCtD
Emtricitabine—Infection—Cisplatin—esophageal cancer	0.00334	0.00384	CcSEcCtD
Emtricitabine—Nervous system disorder—Cisplatin—esophageal cancer	0.0033	0.00379	CcSEcCtD
Emtricitabine—Thrombocytopenia—Cisplatin—esophageal cancer	0.00329	0.00378	CcSEcCtD
Emtricitabine—Skin disorder—Cisplatin—esophageal cancer	0.00326	0.00375	CcSEcCtD
Emtricitabine—Pancreatitis—Methotrexate—esophageal cancer	0.00318	0.00365	CcSEcCtD
Emtricitabine—Immune system disorder—Capecitabine—esophageal cancer	0.00315	0.00362	CcSEcCtD
Emtricitabine—Mediastinal disorder—Capecitabine—esophageal cancer	0.00314	0.00361	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00306	0.00352	CcSEcCtD
Emtricitabine—Mental disorder—Capecitabine—esophageal cancer	0.00306	0.00351	CcSEcCtD
Emtricitabine—Malnutrition—Capecitabine—esophageal cancer	0.00304	0.00349	CcSEcCtD
Emtricitabine—Neutropenia—Methotrexate—esophageal cancer	0.00303	0.00348	CcSEcCtD
Emtricitabine—Paraesthesia—Cisplatin—esophageal cancer	0.00302	0.00347	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00301	0.00346	CcSEcCtD
Emtricitabine—Dyspnoea—Cisplatin—esophageal cancer	0.003	0.00344	CcSEcCtD
Emtricitabine—Back pain—Capecitabine—esophageal cancer	0.00294	0.00337	CcSEcCtD
Emtricitabine—Pneumonia—Methotrexate—esophageal cancer	0.00291	0.00334	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.0029	0.00333	CcSEcCtD
Emtricitabine—Infestation NOS—Methotrexate—esophageal cancer	0.00289	0.00332	CcSEcCtD
Emtricitabine—Infestation—Methotrexate—esophageal cancer	0.00289	0.00332	CcSEcCtD
Emtricitabine—Depression—Methotrexate—esophageal cancer	0.00288	0.00331	CcSEcCtD
Emtricitabine—Pain—Cisplatin—esophageal cancer	0.00287	0.0033	CcSEcCtD
Emtricitabine—Renal failure—Methotrexate—esophageal cancer	0.00284	0.00327	CcSEcCtD
Emtricitabine—Anaemia—Capecitabine—esophageal cancer	0.00281	0.00322	CcSEcCtD
Emtricitabine—Haematuria—Methotrexate—esophageal cancer	0.00276	0.00317	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.00274	0.00314	CcSEcCtD
Emtricitabine—Body temperature increased—Cisplatin—esophageal cancer	0.00266	0.00305	CcSEcCtD
Emtricitabine—Cough—Capecitabine—esophageal cancer	0.00265	0.00304	CcSEcCtD
Emtricitabine—Hepatitis—Methotrexate—esophageal cancer	0.0026	0.00298	CcSEcCtD
Emtricitabine—Myalgia—Capecitabine—esophageal cancer	0.00258	0.00297	CcSEcCtD
Emtricitabine—Arthralgia—Capecitabine—esophageal cancer	0.00258	0.00297	CcSEcCtD
Emtricitabine—Pharyngitis—Methotrexate—esophageal cancer	0.00258	0.00296	CcSEcCtD
Emtricitabine—Anxiety—Capecitabine—esophageal cancer	0.00258	0.00296	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00257	0.00295	CcSEcCtD
Emtricitabine—Urinary tract disorder—Methotrexate—esophageal cancer	0.00256	0.00295	CcSEcCtD
Emtricitabine—Urethral disorder—Methotrexate—esophageal cancer	0.00254	0.00292	CcSEcCtD
Emtricitabine—Hypersensitivity—Cisplatin—esophageal cancer	0.00248	0.00285	CcSEcCtD
Emtricitabine—Infection—Capecitabine—esophageal cancer	0.00246	0.00283	CcSEcCtD
Emtricitabine—Nervous system disorder—Capecitabine—esophageal cancer	0.00243	0.00279	CcSEcCtD
Emtricitabine—Thrombocytopenia—Capecitabine—esophageal cancer	0.00243	0.00279	CcSEcCtD
Emtricitabine—Asthenia—Cisplatin—esophageal cancer	0.00241	0.00277	CcSEcCtD
Emtricitabine—Skin disorder—Capecitabine—esophageal cancer	0.00241	0.00277	CcSEcCtD
Emtricitabine—Immune system disorder—Methotrexate—esophageal cancer	0.00234	0.00269	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methotrexate—esophageal cancer	0.00234	0.00269	CcSEcCtD
Emtricitabine—Diarrhoea—Cisplatin—esophageal cancer	0.0023	0.00264	CcSEcCtD
Emtricitabine—Mental disorder—Methotrexate—esophageal cancer	0.00227	0.00261	CcSEcCtD
Emtricitabine—Malnutrition—Methotrexate—esophageal cancer	0.00226	0.0026	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00226	0.00259	CcSEcCtD
Emtricitabine—Insomnia—Capecitabine—esophageal cancer	0.00224	0.00257	CcSEcCtD
Emtricitabine—Paraesthesia—Capecitabine—esophageal cancer	0.00222	0.00256	CcSEcCtD
Emtricitabine—Dyspnoea—Capecitabine—esophageal cancer	0.00221	0.00254	CcSEcCtD
Emtricitabine—Back pain—Methotrexate—esophageal cancer	0.00219	0.00251	CcSEcCtD
Emtricitabine—Dyspepsia—Capecitabine—esophageal cancer	0.00218	0.00251	CcSEcCtD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—HMGB1—esophageal cancer	0.00218	0.0387	CbGpPWpGaD
Emtricitabine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00214	0.00246	CcSEcCtD
Emtricitabine—Vomiting—Cisplatin—esophageal cancer	0.00214	0.00246	CcSEcCtD
Emtricitabine—Fatigue—Capecitabine—esophageal cancer	0.00214	0.00245	CcSEcCtD
Emtricitabine—Rash—Cisplatin—esophageal cancer	0.00212	0.00244	CcSEcCtD
Emtricitabine—Pain—Capecitabine—esophageal cancer	0.00212	0.00243	CcSEcCtD
Emtricitabine—Dermatitis—Cisplatin—esophageal cancer	0.00212	0.00243	CcSEcCtD
Emtricitabine—Anaemia—Methotrexate—esophageal cancer	0.00209	0.0024	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00203	0.00233	CcSEcCtD
Emtricitabine—Nausea—Cisplatin—esophageal cancer	0.002	0.00229	CcSEcCtD
Emtricitabine—Cough—Methotrexate—esophageal cancer	0.00197	0.00227	CcSEcCtD
Emtricitabine—Urticaria—Capecitabine—esophageal cancer	0.00197	0.00226	CcSEcCtD
Emtricitabine—Abdominal pain—Capecitabine—esophageal cancer	0.00196	0.00225	CcSEcCtD
Emtricitabine—Body temperature increased—Capecitabine—esophageal cancer	0.00196	0.00225	CcSEcCtD
Emtricitabine—Myalgia—Methotrexate—esophageal cancer	0.00192	0.00221	CcSEcCtD
Emtricitabine—Arthralgia—Methotrexate—esophageal cancer	0.00192	0.00221	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00191	0.0022	CcSEcCtD
Emtricitabine—Infection—Methotrexate—esophageal cancer	0.00183	0.00211	CcSEcCtD
Emtricitabine—Hypersensitivity—Capecitabine—esophageal cancer	0.00183	0.0021	CcSEcCtD
Emtricitabine—Nervous system disorder—Methotrexate—esophageal cancer	0.00181	0.00208	CcSEcCtD
Emtricitabine—Thrombocytopenia—Methotrexate—esophageal cancer	0.00181	0.00207	CcSEcCtD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—ABL1—esophageal cancer	0.0018	0.032	CbGpPWpGaD
Emtricitabine—Skin disorder—Methotrexate—esophageal cancer	0.00179	0.00206	CcSEcCtD
Emtricitabine—Asthenia—Capecitabine—esophageal cancer	0.00178	0.00204	CcSEcCtD
Emtricitabine—Pruritus—Capecitabine—esophageal cancer	0.00175	0.00201	CcSEcCtD
Emtricitabine—Diarrhoea—Capecitabine—esophageal cancer	0.0017	0.00195	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00168	0.00193	CcSEcCtD
Emtricitabine—Insomnia—Methotrexate—esophageal cancer	0.00167	0.00192	CcSEcCtD
Emtricitabine—Paraesthesia—Methotrexate—esophageal cancer	0.00166	0.0019	CcSEcCtD
Emtricitabine—Dyspnoea—Methotrexate—esophageal cancer	0.00164	0.00189	CcSEcCtD
Emtricitabine—Dizziness—Capecitabine—esophageal cancer	0.00164	0.00188	CcSEcCtD
Emtricitabine—Dyspepsia—Methotrexate—esophageal cancer	0.00162	0.00187	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00159	0.00183	CcSEcCtD
Emtricitabine—Fatigue—Methotrexate—esophageal cancer	0.00159	0.00183	CcSEcCtD
Emtricitabine—Pain—Methotrexate—esophageal cancer	0.00158	0.00181	CcSEcCtD
Emtricitabine—Vomiting—Capecitabine—esophageal cancer	0.00158	0.00181	CcSEcCtD
Emtricitabine—Rash—Capecitabine—esophageal cancer	0.00156	0.00179	CcSEcCtD
Emtricitabine—Dermatitis—Capecitabine—esophageal cancer	0.00156	0.00179	CcSEcCtD
Emtricitabine—Headache—Capecitabine—esophageal cancer	0.00155	0.00178	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00151	0.00173	CcSEcCtD
Emtricitabine—Nausea—Capecitabine—esophageal cancer	0.00147	0.00169	CcSEcCtD
Emtricitabine—Urticaria—Methotrexate—esophageal cancer	0.00147	0.00168	CcSEcCtD
Emtricitabine—Abdominal pain—Methotrexate—esophageal cancer	0.00146	0.00168	CcSEcCtD
Emtricitabine—Body temperature increased—Methotrexate—esophageal cancer	0.00146	0.00168	CcSEcCtD
Emtricitabine—Hypersensitivity—Methotrexate—esophageal cancer	0.00136	0.00156	CcSEcCtD
Emtricitabine—Asthenia—Methotrexate—esophageal cancer	0.00132	0.00152	CcSEcCtD
Emtricitabine—Pruritus—Methotrexate—esophageal cancer	0.0013	0.0015	CcSEcCtD
Emtricitabine—Diarrhoea—Methotrexate—esophageal cancer	0.00126	0.00145	CcSEcCtD
Emtricitabine—Dizziness—Methotrexate—esophageal cancer	0.00122	0.0014	CcSEcCtD
Emtricitabine—Vomiting—Methotrexate—esophageal cancer	0.00117	0.00135	CcSEcCtD
Emtricitabine—Rash—Methotrexate—esophageal cancer	0.00116	0.00134	CcSEcCtD
Emtricitabine—Dermatitis—Methotrexate—esophageal cancer	0.00116	0.00133	CcSEcCtD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—RB1—esophageal cancer	0.00116	0.0207	CbGpPWpGaD
Emtricitabine—Headache—Methotrexate—esophageal cancer	0.00116	0.00133	CcSEcCtD
Emtricitabine—Nausea—Methotrexate—esophageal cancer	0.0011	0.00126	CcSEcCtD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—esophageal cancer	0.000862	0.0153	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—esophageal cancer	0.000834	0.0148	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—esophageal cancer	0.000692	0.0123	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—BLVRB—esophageal cancer	0.00062	0.011	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—SLC52A3—esophageal cancer	0.00062	0.011	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—esophageal cancer	0.000568	0.0101	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CA1—esophageal cancer	0.000527	0.00938	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—SLC10A2—esophageal cancer	0.000527	0.00938	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CA2—esophageal cancer	0.000482	0.00858	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PLCE1—esophageal cancer	0.000448	0.00798	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ADH7—esophageal cancer	0.000448	0.00798	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ADH1B—esophageal cancer	0.000393	0.007	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—TYMP—esophageal cancer	0.000376	0.00669	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CYP26A1—esophageal cancer	0.000365	0.0065	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ALOX15—esophageal cancer	0.000356	0.00634	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GSTO1—esophageal cancer	0.00034	0.00605	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—TPI1—esophageal cancer	0.00034	0.00605	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ALDOB—esophageal cancer	0.000326	0.0058	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GAPDH—esophageal cancer	0.000314	0.00558	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CRABP1—esophageal cancer	0.000311	0.00553	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GNG7—esophageal cancer	0.000296	0.00526	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ALDH2—esophageal cancer	0.000277	0.00493	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GSTT1—esophageal cancer	0.000263	0.00469	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CYP2A6—esophageal cancer	0.00026	0.00463	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ENO1—esophageal cancer	0.000247	0.00439	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PTGS1—esophageal cancer	0.000247	0.00439	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PSME2—esophageal cancer	0.000243	0.00433	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PSME1—esophageal cancer	0.000243	0.00433	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CYP1B1—esophageal cancer	0.00021	0.00374	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CYP19A1—esophageal cancer	0.000197	0.00351	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—HMOX1—esophageal cancer	0.00018	0.00321	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ABCB1—esophageal cancer	0.000173	0.00308	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CREBBP—esophageal cancer	0.000116	0.00206	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NOS3—esophageal cancer	0.000103	0.00184	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PTGS2—esophageal cancer	9.46e-05	0.00168	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—EP300—esophageal cancer	7.87e-05	0.0014	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PIK3CA—esophageal cancer	5.82e-05	0.00104	CbGpPWpGaD
